Primary Record
Vapreotide
- In stock
- 5,230 g
- Purity
- 98.1 %
- CAS
- 103222-11-3
Compound Identifiers & Properties
- CAS
- 103222-11-3
- PubChem CID
- 6918026
- SMILES
- CC(C)[C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@@H](CC6=CNC7=CC=CC=C76)C(=O)N
- Canonical SMILES
- CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(N)=O)NC1=O
Names & Synonyms
- Vapreotide
- Vapreotida
- Vapreotidum
- Sanvar IR
- Vapreotide acetate
- AC1OCEXJ
- Vapreotidum [INN-Latin]
- 2PK59M9GFF
- CCRIS 6495
- Vapreotida [INN-Spanish]
- UNII-2PK59M9GFF
- VAPREOTIDE [MI]
- RC-160
- VAPREOTIDE [INN]
- 103222-11-3
- RefChem:193718
- Vapreotide [USAN:INN]
- VAPREOTIDE [USAN]
- RC 160
- Vapreotide [USAN:INN:BAN]
- SCHEMBL4826
- VAPREOTIDE [MART.]
- VAPREOTIDE [WHO-DD]
- BMY 41606
- BMY-41606
- CHEMBL3349523
- DTXSID00883113
- Vapreotide trifluoroacetate salt
- SCHEMBL31632623
- H01CB04
- MFCD30489723
- DTXCID201022687
- GLXC-21146
- C57H70N12O9S2
- EX-A7487
- BDBM50474224
- D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2
- AKOS024457453
- BAT-006135
- CID6918026
- DB04894
- C57-H70-N12-O9-S2
- NCGC00167342-01
- A800694
- H-D-Phe-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Trp-NH2
- N0001-012319
- D-Phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-tryptophanamide cyclic (2->7)-disulfide
- D-phenylalanyl-cysteinyl-tyrosyl-D-tryptophyl-lysyl-valyl-cysteinyl-tryptophanamide
- (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
- L-Tryptophanamide, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2->7)-disulfide
- (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-((2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-19-(((2R)-2-amino-3-phenylpropanoyl)amino)-16-((4-hydroxyphenyl)methyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
- (4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-16-[(4-hydroxyphenyl)methyl]-13-[(1H-indol-3-yl)methyl]-6,9,12,15,18-pentaoxo-19-(D-phenylalanylamino)-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
- 2-amino-N-(10-(4-aminobutyl)-4-((1-carbamoyl-2-(1H-indol-2-yl)ethyl)carbamoyl)-16-((4-hydroxyphenyl)methyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl)-3-phenylpropanamide
- D-PHENYLALANYL-L-CYSTEINYL-L-TYROSYL-D-TRYPTOPHYL-L-LYSYL-L-VALYL-L-CYSTEINYL-L-TRYPTOPHANAMIDE CYCLIC (2->7)-DISULPHIDE
- D-Phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-tryptophanamide cyclic (2-7)-disulfide
- D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-tryptophanamide, cyclic (2-->7)-disulfide
- L-TRYPTOPHANAMIDE, D-PHENYLALANYL-L-CYSTEINYL-L-TYROSYL-D-TRYPTOPHYL-L-LYSYL-L-VALYL-L-CYSTEINYL-, CYCLIC (2->7)-DISULPHIDE
- L-Tryptophanamide, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide
- L-Tryptophanamide, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide-